** South Korean President Orders Military to Act Without Political Considerations Against North Korean Actions**
South Korea's president has made her strongest remarks yet in the escalating war of words with North Korea.
In a meeting Monday with defense ministry officials, President Park Geun-hye is quoted as ordering them to respond early and strongly to any provocation from North Korea, and without any regard to political consequences.
In recent weeks, North Korea has increased tensions with repeated threats of war against the South and the United States in anger over joint military exercises, as well as tightened U.N. Security Council resolutions for its third nuclear test.
It is not clear how Ms. Park's order will affect the U.S. military, which signed an agreement earlier this month giving American troops an expanded role in protecting the South from North Korean provocation.
** Drug Maker Loses India Patent Battle**
India's Supreme Court has rejected a patent bid by Swiss drug maker Novartis for a cancer drug.
In a landmark ruling Monday, the court dismissed patent protection to an updated version of the drug Glivec.
The ruling is a precedent that prevents international pharmaceutical companies from obtaining fresh patents in India on updated versions of existing drugs.
India's law prevents companies from seeking patents for making only slight modifications to an existing drug.
The Supreme Court decided Monday the updated Glivec did not satisfy the "novelty" aspect required by Indian patent law.
The ruling is a victory for India's multi-billion-dollar generic drug industry that provides cheap medicines to millions around the world.
Novartis has been fighting since 2006 to win a patent for the amended form of Glivec.